CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 4 Open-market buy President, CEO, COB bought 400 shares at an average $3.95 ($1,579)
- 4 Open-market buy Chief Financial Officer bought 7,600 shares at $5.71 ($43,396)
- 4 Open-market buy 10% owner bought 2,500 shares at $5.66 ($14,150)
- 4 Open-market buy 10% owner bought 46,000 shares at an average $5.71 ($262,640)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 15,700 shares at an average $4.85 ($76,088)
- 10-K Report Annual Report
- 4 Open-market buy 10% owner bought 155,950 shares at an average $5.09 ($794,110)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award VP of Research and Development acquired 12,438 shares (grant or award)
- 4 Grant or award President, CEO, COB acquired 12,438 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy President, CEO, COB bought 1,470 shares at $3.40 ($4,998)
- 4 Open-market buy President, CEO, COB bought 2,000 shares at $3.85 ($7,700)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market buy President, CEO, COB bought 799 shares at $5.50 ($4,395)
- 4 Open-market buy President, CEO, COB bought 2,500 shares at $6.00 ($15,000)
- RW Other RW
Page 13 of 38 · 755 filings